Remed
리메드 · 302550
Health Care Medical Devices · KOSDAQ
Market cap US$63.3M (₩87.3B)
Overview
Remed makes medical devices that use powerful magnetic fields and other energy-based technologies to treat neurological and psychiatric conditions, such as depression, ADHD, and stroke, as well as to manage pain and support physical rehabilitation, all without surgery.
Its products are used in clinical and hospital settings by medical professionals. The company's portfolio spans brain-stimulation devices, pain-management systems, and energy-based aesthetic and dermatology equipment, giving it a broad range across both therapeutic and cosmetic medical applications. Remed is listed on KOSDAQ, South Korea's technology and small-cap stock exchange.
Summary is AI-generated and may contain errors · figures from DART filings
Financials
Source: DART · FY ending Dec · latest FY2025Revenue
- FY2023US$13.4M
- FY2024US$18.5M
- FY2025US$17.8M
Operating profit
- FY2023−US$2.1M
- FY2024US$812.5K
- FY2025US$526K
Net income
- FY2023US$231.3K
- FY2024US$5.3M
- FY2025−US$25.7K
Key ratios (FY2025)
Price charts coming soon
Interactive price history isn't here yet. Would you use it?